QQ客服 官方微博 反馈留言

	Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol.
	Pan Xiaoyan; Liang Liyuan; Si Ru; Wang Jin; Zhang Qingqing; Zhou Huaxin; Zhang Lin; Zhang Jie
刊名	European journal of medicinal chemistry
	2019
卷号	163页码:1-9
关键词	Anti-angiogenic agents Triple RTK inhibitors 1,2,3-Triazole DFG-binding group Multi-target
ISSN号	1768-3254
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2828772
专题	西安交通大学
推荐引用方式 GB/T 7714	Pan Xiaoyan,Liang Liyuan,Si Ru,et al. Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol.[J]. European journal of medicinal chemistry,2019,163:1-9.
APA	Pan Xiaoyan.,Liang Liyuan.,Si Ru.,Wang Jin.,Zhang Qingqing.,...&Zhang Jie.(2019).Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol..European journal of medicinal chemistry,163,1-9.
MLA	Pan Xiaoyan,et al."Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol.".European journal of medicinal chemistry 163(2019):1-9.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。